Efficacy and Safety Analysis of First-Line ABCP Therapy in Advanced SMARCA4-Mutated NSCLC
Clinical trial NCT07093762 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07093762
- Sponsor
- Fuzhou General Hospital
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-08-20
- Primary completion
- 2028-06-30
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.